August 4, 2011 — A new study is the first long-term prospective trial of dopamine agonist therapy in restless legs syndrome (RLS). The study, funded by UCB BioSciences and Schwarz Pharma, ...
BERLIN — Patients with restless legs syndrome (RLS) for whom conventional therapies are contraindicated may benefit from a treatment usually reserved for patients with advanced Parkinson's disease and ...
Credit: Getty Images The American Academy of Sleep Medicine published guidance regarding the treatment of restless leg syndrome and periodic limb movement disorder. The American Academy of Sleep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results